<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Shenzhen_SFLS_HP_CRISPR_Popularization_CRISPR_Questionnaire skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Shenzhen SFLS/HP/CRISPR Popularization CRISPR Questionnaire</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Team:Shenzhen SFLS/Demonstrate - 2017.igem.org</TITLE></P><DIV id="header"><NAV class="sfls-nav" role="navigation"><DIV class="container"><DIV class="row"><DIV class=" text-center menu-1 "><UL><LI class="has-dropdown"><A href="https://2017.igem.org/Team:Shenzhen_SFLS">Project</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Description ">Description</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Design ">Design</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Experiments ">Experiment</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Demonstrate ">Demonstrate</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Collaborations ">Collaboration</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Achievement ">Achievement</A></LI></UL><LI class="has-dropdown"><A href="#">Parts</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Basic_Part ">basic part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Composite_Part ">composite part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Model">Modeling</A></LI><LI class="has-dropdown"><A href="#">Human Practice</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Gold_Integrated ">GOLD</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Silver ">SILVER</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Publicity ">Publicity</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Biosafety ">Biosafety</A></LI><LI class="has-dropdown"><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Notebook ">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Notebook ">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Protocols ">protocols</A></LI><LI class="has-dropdown"><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Team">Team</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Team">About us</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Attributions ">Attributions</A></LI></DIV></DIV></DIV></NAV></DIV><TITLE>Team:Shenzhen SFLS/Experiment - 2017.igem.org</TITLE><DIV class="img_head_bar text-center"><DIV class="display-t" style="background-image:url(https://static.igem.org/mediawiki/2017/f/f8/Sfls-title-HP.svg); background-repeat:no-repeat; background-attachment:fixed"><DIV class="display-tc"><H1>CRISPR Popularization</H1></DIV></DIV></DIV><DIV class="marin_top"><DIV class="marin_top_content"><DIV id="tbox"><UL class="ul_t"><LI class="taoyu" href="#index_1"><DIV class="taoyu_title"><A href="#index_1" title="1">CRISPR Questionnaire</A></DIV></LI><LI class="taoyu" href="#index_2"><DIV class="taoyu_title"><A href="#index_2" title="2">CRISPR Articles</A></DIV></LI><LI class="taoyu" href="#index_3"><DIV class="taoyu_title"><A href="#index_3" title="3">Related Activities</A></DIV></LI></UL></DIV><DIV class="main_context" id="main"><DIV class="row"><DIV class="mainpage mainpage1"><H5 id="index_1">CRISPR Questionnaire</H5><P>We conducted a survey to investigate common public misconceptions about CRISPR. </P><H6>Question 3: What is CRISPR?</H6><P>Result: Through this survey, we found the public knew the application of CRISPR. It maybe caused by the popularization of CRISPR application through mass media. 48.8% of the participants considered CRISPR a kind of immune system. ( Answer for Question 3 - It is a kind of immune system. )</P><P>However, people had no idea about the origin of CRISPR</P><H6>Question 4: What is the origin of CRISPR?</H6><P>Result: According to the data above, we found that only about half of the participants knew that CRISPR originated from germs.( Answer for Question 4 - It comes from germs )</P><P>We also raised questions about ethical issues of CRISPR to investigate the attitudes towards CRISPR of the public. </P><H6>Question 5: What do you think about the treatment of using CRISPR? </H6><P>Result: More than 90% of the people thought it had broad prospects. </P><H6> Question 6: Whether CRISPR could be used in the issues of human’s gene?</H6><P>Result:About 78.85% of the participants considered CRISPR could be used in treatment of human,which indicated that most of people believed CRISPR could benefit human beings. However, there were still a minority of people doubt about the potential ethical issues and the future development of CRISPR.</P><P>In conclusion, the public’s attitude towards CRISPR is optimistic.They believed that  CRISPR technology has a great prospect in the future.  </P></DIV></DIV><DIV class="row"><DIV class="mainpage mainpage2"><H5 id="index_2">CRISPR articles</H5><P>We published a summary article about our result of CRISPR investigation on our WeChat Official Account and online forum ZhiHu. In this article, we showed the right answers of this questionnaire, the pros and cons of CRISPR/Cas9 system and its prospects. </P><P>P1:The CRISPR investigation article we published at our Wechat official account </P><P>P2:The CRISPR investigation article we published on online forum ZhiHu </P></DIV></DIV><DIV class="row"><DIV class="mainpage mainpage3"><H5 id="index_3">Related activities</H5><P>On October 25, BGIC-Unoin and our team conducted an activity at Class3 Grade 6, Donghai Primary School Attached to Shenzhen Foreign Languages School.</P><P>We started the activity with a series of quiz . </P><P>Then we told them some stories about the history of biology research and introduced them some basic knowledge of DNA. After that we played a DNA base-paring game with the children, leading them to learn more about biology. </P><P>Before ending the class, we gave out the same questionnaire to the children again and investigated the influence our activity exerted on them </P><P>Our statistics showed that our biology class seemed pretty successful.</P><P>Statistics before the speech</P><P>Statistics after the speech</P><P>On 27th Oct 2017, BGIC-Unoin and our team went to Shenzhen Baihe Foreign Language School to give a speech about our project. The content of the speech included iGEM introduction, cancer introduction, gene therapy and CRISPR/Cas 9 system.</P><P>After the speech, we conducted a survey about CRISPR. From the statistics we can know that after our presentation students have a clearer understanding of the related information about CRISPR, our speech focus.</P></DIV></DIV></DIV></DIV><DIV class="img_bottom_bar  text-center"><DIV class="display-t"><DIV class="display-tc"><H1> </H1></DIV></DIV></DIV><FOOTER id="sfls-footer" role="contentinfo"><DIV class="container"><DIV class="row row-pb-md"><DIV class="col-md-4 sfls-widget"><H3><A href="home.html">SFLS.</A></H3><P id="ours">Shenzhen Foreign Language School, Yantian Road No.1, Yantian District, Shenzhen, Guangdong, China</P></DIV><DIV class="col-md-2 col-sm-4 col-xs-6 col-md-push-1"><UL class="sfls-footer-links"><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS">Home</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Description ">Description</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Design ">Design</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Experiments ">Experiment</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Demonstrate ">Demonstrate</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Collaborations">Collaboration</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Achievement">Achievement</A></LI></UL></DIV><DIV class="col-md-2 col-sm-4 col-xs-6 col-md-push-1"><UL class="sfls-footer-links"><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Basic_Part ">Basic Part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Composite_Part ">Composite Part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Model ">Modeling</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Silver ">HP-Silver</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Gold_Integrated ">HP-Gold</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Biosafety ">Biosafety</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Protocols">Protocols</A></LI></UL></DIV><DIV class="col-md-2 col-sm-4 col-xs-6 col-md-push-1"><UL class="sfls-footer-links"><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Team ">About us</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Attributions ">Attribution</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Engagement">Engagement</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Contribution">Contribution</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Notebook ">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Publicity ">Publicity</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Improve">Improve</A></LI></UL></DIV></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>